Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Vocka M, Zimovjanova M, Bielcikova Z, Tesarova P, Petruzelka L, Mateju M, Krizova L, Kotlas J, Soukupova J, Janatova M, Zemankova P, Kleiblova P, Novotny J, Konopasek B, Chodacka M, Brychta M, Sochor M, Smejkalova-Musilova D, Cmejlova V, Kozevnikovova R, Miskarova L, Argalacsova S, Stolarova L, Lhotova K, Borecka M, Kleibl Z.

Cancers (Basel). 2019 May 28;11(6). pii: E738. doi: 10.3390/cancers11060738.

2.

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.

Jakabova A, Bielcikova Z, Pospisilova E, Matkowski R, Szynglarewicz B, Staszek-Szewczyk U, Zemanova M, Petruzelka L, Eliasova P, Kolostova K, Bobek V.

Breast Cancer Res Treat. 2017 Dec;166(3):695-700. doi: 10.1007/s10549-017-4452-9. Epub 2017 Aug 16.

3.

Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?

Bielčiková Z, Jakabová A, Pinkas M, Zemanová M, Kološtová K, Bobek V.

Am J Transl Res. 2017 Jun 15;9(6):2807-2823. eCollection 2017.

Supplemental Content

Loading ...
Support Center